‘9-1-1’ Actress Shares ‘Traumatic’ Experience Terminating Pregnancy Over ‘Rare Genetic Disease’: ‘The Worst Pain’

‘9-1-1’ Actress Opens Up About Terminating Pregnancy Due to Rare Genetic Disease

Justene Alpert, widely recognized for her role in the hit television series ‘9-1-1,’ recently shared a deeply personal and emotional story about her experience terminating a pregnancy after discovering her unborn child was diagnosed with a rare genetic disease. In a heartfelt Instagram post, Alpert revealed the trauma and grief she and her husband, Mason Trueblood, endured during this difficult time.

The devastating news came as Alpert was entering her second trimester in late 2025. After routine checkups, she was rushed to a genetic specialist who confirmed the heartbreaking diagnosis: their baby was unlikely to survive to full term. The specialist strongly recommended terminating the pregnancy due to the high risks involved, urging the couple to make a swift decision.

This revelation shattered the couple’s joy, especially as they had just begun sharing the exciting news of their pregnancy with family and friends. Alpert described the moment as “the worst pain,” emphasizing how no one truly prepares parents-to-be for such a traumatic experience.

The Emotional Toll of Facing a Rare Genetic Disease Diagnosis

Alpert’s candid account sheds light on the emotional turmoil that accompanies a pregnancy complicated by a rare genetic condition. She recounted how the initial phone call from the specialist instantly drained her happiness and light. During the subsequent ultrasound, doctors pointed out abnormalities in the baby’s fluids and organs, confirming the grim prognosis.

The actress expressed how the decision to terminate was not made lightly. Both she and her husband grappled with intense grief, praying for either a miracle or a natural miscarriage. The couple spent Christmas quietly, trying to savor their last moments with their unborn son, whom they had already begun to love deeply.

Alpert also highlighted the lack of open conversations around pregnancy termination due to genetic diseases. She noted the unfair stigma, shame, and guilt that many parents face in such situations, emphasizing that these experiences often lack the empathy and understanding they deserve.

The Aftermath: Coping with Loss and Finding Strength

The termination procedure took place on December 29, 2025. Alpert described the physical and emotional pain as overwhelming, stating she was “throwing up from the grief and trauma.” Despite the heartbreak, she and her husband remained united, supporting each other through the darkest moments.

In her post, Alpert reflected on how the experience deepened her love for Mason. Their bond grew stronger as they navigated the sorrow together, embodying the vows of being there “for better or for worse, in sickness and in health.” She shared that their New Year’s Eve was spent quietly, cuddling on the couch, still a strong unit despite their tears.

To honor their son, whom they named Mads Mason Trueblood, Alpert wrote a touching letter expressing gratitude for the brief time they had with him. She acknowledged that becoming a mother, even for a short time, gave her strength and courage she hadn’t anticipated.

Raising Awareness and Offering Support to Others

By sharing her story publicly, Justene Alpert hopes to reach other women and families who might be feeling isolated, shattered, or frantic after receiving similar diagnoses. She emphasized the importance of empathy and understanding for parents facing such heartbreaking decisions.

Alpert also thanked her support system—friends, family, and fans—who provided comfort through calls, texts, flowers, and gestures of kindness. Her openness aims to break the silence surrounding pregnancy termination due to rare genetic diseases and encourage others to seek help and community.

Conclusion

Justene Alpert’s brave disclosure about her traumatic experience terminating a pregnancy over a rare genetic disease brings much-needed awareness to a deeply personal and often stigmatized issue. Her story highlights the emotional pain, the strength required to make such decisions, and the importance of support and empathy for families facing similar challenges. If you or someone you know is going through a difficult pregnancy diagnosis, remember you are not alone—reach out to loved ones and professional counselors who can provide guidance and comfort during this trying time.

If this story resonates with you, please share it to help raise awareness and foster a supportive community for those affected by rare genetic diseases and pregnancy loss.